Privia Health Group, Inc. (PRVA) research
Privia Health Group, Inc.- Sector
- Health Care
- Last price
- $19.46
- As of
Privia Health Group, Inc. (PRVA): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-18.
As of . Source: SEC EDGAR filings for PRVA. Method and limitations.
Share the PRVA intelligence card
See PRVA live in the terminal
Track PRVA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live PRVA terminal, freeActive signals for PRVA
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 62% of PRVA (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 85% of PRVA (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 75% of PRVA (2026Q2)
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +114% to PRVA (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 62% of PRVA (2026Q2)
FREE, NO ACCOUNT
Every signal on PRVA, as it fires
You are seeing 5 of 18 signals recorded on PRVA since 2026-05-17.
The five above all landed on 2026-09-06. The other 13 were recorded on 2 other days. 14 of the 18 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PRVA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 74276R102 · 2026Q2 | $16.3M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 74276R102 · 2026Q2 | $9.1M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 74276R102 · 2026Q2 | $6.9M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 74276R102 · 2026Q2 | $1.3M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PRVA
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PRVA against its peers
PRVA's operating margin of 1.6% ranks in the 40th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | PRVA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.1B USD | 1.3B USD | 67 | 25 |
| Gross margin | n/a | 57.3% | n/a | 20 |
| Operating margin | 1.6% | 6.0% | 40 | 23 |
| Net margin | 1.1% | 2.7% | 44 | 25 |
| Return on equity | 3.1% | 5.2% | 46 | 24 |
| P / E | 108.1x | 31.4x | 90 | 14 |
Peers (25): ACHC, BKD, INSP, ATRC, AVAH, TMDX, WGS, ALHC, MD, PGNY, SEM, XRAY, NVCR, LMAT, CRVL, IRTC, OPCH, NVST, ATEC, OMCL, LIVN, ITGR, PNTG, CNMD, DOCS. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (PRVA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PRVA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PRVAand get the insider, 13F, options, and confluence read in one view.